Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 27, 1997 - Issue 2
35
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Aflatoxin B1 epoxidation catalysed by partially purified human liver lipoxygenase

&
Pages 231-241 | Published online: 22 Sep 2008

References

  • AMSTAD, P. and CERRUTI, P., 1983, DNA binding of aflatoxinBi-2,3- oxide: evidence for its formation in rat liver in vivo and by human liver microsomes. Biochemical Biophysical Research Communications, 60, 1036–1043.
  • BATTISTA, J. R., and M ARNETT, L. J., 1985, Prostaglandin H- synthase- dependent epoxidation of aflatoxin B. Carcinogenesis, 6, 1227–1229.
  • BYCZKOWSKI, J. Z. and K ULKARNI, A. P., 1992, Linoleate- dependent co-oxygenation of benzo(a)pyrene and benzo(a)pyrene- 7,8- dihydrodiol by rat lung cytosolic lipoxygenase. Xenobiotica, 22, 609–618.
  • CLAESSON, H. E., O DLANDER, B. and JAKOBSSON, P. J., 1992, Leukotriene B4 in the immune system. International Journal of Immunopharmacology, 14, 441–449.
  • DATTA, K., JOSEPH, P., ROY, S. K., SRINIVASAN, S. N. and KULKARNI, A. P., 1995, Peroxidative xenobiotic metabolism by purified peroxidase and lipoxygenase from human fetal tissues at 10 weeks of gestation. Genetics and Pharmacology, 26, 107–112.
  • DATTA, K. and K ULKARNI, A. P., 1994, Oxidative metabolism of aflatoxin Bi by lipoxygenase purified from human term placenta and intrauterine conceptal tissues. Teratology, 50, 311–317.
  • DONNELLY, P. J., Au, S. L., CONLAN, A. A. and M ASSEY T. E., 1994, Arachidonic acid dependent bioactivation of aflatoxin Bi in human lung. Toxicologist, 14, 336.
  • FIROZI, P. F., ABOOBAKER, V. S. and BHATTACHARYA, R. K., 1986, Modulation by certain factors of metabolic activation of aflatoxin Bi as detected in vitro in a simple fluorimetric assay. Chemico Biological Interactions, 59, 173–184.
  • FLAMMANG T. J., YAMAZOE, Y., BENSON, R. W., ROBERTS, D. W., POTTER, D. W., CHU, D. Z. J., LANG, N. P. and K ADLUBAR, F. F., 1989, Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes. Cancer Research, 49, 1977–1982.
  • HAGMANN W., KAISER, I. and JAKSCHIK, B. A., 1991, The sensitized liver represents a rich source of endogenous leukotrienes. Hepatology, 13, 482–488.
  • HAGMANN W., S TEFFAN, A. M K IRN, A. and KEPPLER, D., 1987, Leukotrienes as mediators in frog virus 3-induced hepatitis in rats. Hepatology, 7, 732–736.
  • HATZELMANN, A., SCHATZ, M. and ULLRICH, V., 1989, Involvement of glutathione peroxidase activity in the stimulation of 5-lipoxygenase activity by glutathione-depleting agents in human polymorpho-nuclear leukocytes. European Journal of Biochemistry 180, 527–533.
  • HO, T. A., COUTTS, T. M., ROWLAND, I. R. and ALLDRICK, A. J., 1992, Inhibition of the metabolism of the mutagens occurring in food by arachidonic acid. Mutation Research, 269, 279–284.
  • HUGHES, H., FARHOOD, A. and JAESCHKE, H., 1992, Role of leukotrine 134 in the pathogenesis of hepatic ischaemia-reperfusion injury in the rat. Prostaglandins, Leukotrienes and Essential Fatty Acids, 45, 113–119.
  • JENNING, G. S., HECK, R., OESCH, F. and S TEINBERG, P., 1992, Metabolism and cytotoxicity of aflatoxin B in cultured rat hepatocytes and non-parenchymal cells: Implications for tumorigenesis. Toxicology and Applied Pharmacology, 129, 86–94.
  • JENNING, G. S., OESCH, F. and S TEINBERG, P., 1994, In vivo formation of aflatoxin B1—DNA adducts in parenchymal and non-parenchymal cells of rat liver. Carcinogenesis, 13, 831–835.
  • JOSEPH, P., SRINIVASAN, S. N., BYCZKOWSKI, J. Z. and KULKARNI, A. P., 1994, Bioactivation of benzo(a)pyrene- 7,8-dihydrodiol catalyzed by lipoxygenase purified from human term placenta and conceptual tissues. Reproductive Toxicology, 8, 307–313.
  • JOSEPH, P., S RINIVASAN, S. N. and K ULKARNI, A. P., 1993, Purification and partial characterization of lipoxygenase with dual activities from human term placenta. Biochemical Journal, 293, 83–91.
  • KAWADA, N., MIZOGUCHI, Y., KOBAYASHI, K., YAMAMOTO, S. and MORISAWA, S., 1990, Arachidonic acid metabolites in carbon-tetrachloride- induced liver injury. Gastroenterologica Japanica, 25, 363–368.
  • KAWADA, N., UEDA, N., M IZOGUCHI, Y., KOBAYASHI, K., M ONNA, T., M ORISAWA S., I SHIMURA, K., Suzum, T. and YAMAMOTO, 5., 1992, Increased 5-lipoxygenase activity in massive hepatic cell necrosis in the rat correlates with neutrophil infiltration. Hepatology, 16, 462–468.
  • KUHN, H., GOTZE, R., S CHEWE, T., and RAPOPORT, S. M., 1981, Quasi-lipoxygenase activity of hemoglobin: a model for lipoxygenases. European Journal of Biochemistry, 120, 161–168.
  • KULKARNI, A. P., 1996, Role of xenobiotic metabolism in developmental toxicity. In Handbook of Developmental Toxicology, edited by R. D. Hood (Boca Raton: CRC Press), pp. 383–421.
  • KULKARNI, A. P., CAI, Y. and RICHARDS, I. S., 1992, Rat pulmonary lipoxygenase: dioxygenase activity and role in xenobio tic metabolism. International Journal of Biochemistry, 24, 255–261.
  • LANG, B., FR, K. and MAIER, P., 1986, Prostaglandin synthase dependent aldrin epoxidation in hepatic and extrahepatic tissues of rats. Biochemical Pharmacology, 35, 3643–3644.
  • LIU, L. and M ASSEY T. E., 1992, Bioactivation of aflatoxin B by lipoxygenases, prostaglandin H synthase and cytochrome P450 monooxygenase in guinea-pig tissues. Carcinogenesis, 13, 533–539.
  • LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
  • MACIAS, P., PINTO, M. C., and CAMPILLO, J. E., 1987, Purification and partial characterization of rat liver lipoxygenase. Verlag der Zeitschrift fur Naturforschung, 42, 1343–1348.
  • MALLE E., L EIS, H. J., K ARADI, I. and KOSTNER, C. M., 1987, Lipoxygenases and hydroperoxy /hydroxy eicosatetraenoic acid formation. International Journal of Biochemistry, 19, 1013–1022.
  • MARUYAMA, T., UEDA, N., YOSHIMOTO, T., YAMAMOTO, S., K OMATSU, N. and W ATANABE K., 1989, Immunohistochem ical study of arachidonate 12-lipoxygenase in porcine tissues. Journal of Histochemistry and Cytochemistry, 37, 1125–1131.
  • MASSEY T. E., S TEWART, R. K., DANIELS, J. M. and Liu, L., 1995, Biochemical and molecular aspects of mammalian susceptibility to Aflatoxin Bi carcinogenicity. Proceedings of Society for Experi-mental Biology and Medicine, 208, 213–227.
  • MEAD, J. F., ALFIN -SLATER, R. B., HOWTON, D. R. and POPJAK, G., 1986, Lipids-Chemistry, Biochemistry and Nutrition, edited by J. F. Mead (New York: Plenum), pp. 135–172.
  • NAIDU, A. K., NAIDU, A. K. and K ULKARNI, A. P., 1992, Dioxygenase and hydroperoxidase activities of rat brain cytosolic lipoxygenase. Research Communications in Chemical Pathology and Pharmacology, 75, 347–356.
  • NEMOTO, N. and T AKAYAMA, S., 1983, Effects of unsatura ted fatty acids on metabolism of benzo(a)pyrene in an NADPH- fortified rat liver microsomal system. Carcinogenesis, 4, 1253–1257.
  • NEMOTO, N. and T AKAYAMA, S., 1984, Arachidonic acid-dependent activation of benzo(a)pyrene to bind to proteins with cytosolic and microsomal fractions from rat liver and lung. Carcinogenesis, 5, 961–964.
  • NEWBERNE, P. M. and BUTLER, W. H., 1969, Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: a review. Cancer Research, 29, 236–250.
  • PEREIRA, T. A. and D AS, N. P., 1991, Assay of liver cytosol lipoxygenase by differential pulse polarography. Annalytical Biochemistry, 197, 96–100.
  • PEREZ, H. D., ROLL, F. J., BISSELL, D. M., S HAK, S. and GOLDSTEIN, I. M., 1984, Production of chemotactic activity for polymorphonuclear leukocytes by cultured rat hepatocytes exposed to ethanol. Journal of Clinical Investigation, 74, 1350–1357.
  • PRASANNA, H. R., Lu, M. H., BELAND, F. A. and HART, R. W., 1989, Inhibition of aflatoxin B1 binding to hepatic DNA by dehydroepiandro sterone in vivo. Carcinogenesis, 12, 2197–2200.
  • RAMSDELL, H. S. and EATON, D. L., 1990, Species susceptibility of aflatoxin Bi carcinogenesis : Comparative kinetics of microsomal biotransformation. Cancer Research, 50, 615–620.
  • ROLL, F. J., BISSELL, D. M. and PEREZ, H. D., 1986, Human hepatocytes metabolizing ethanol generate a nonpolar chemotactic factor for human neutrophils. Biochemical and Biophysical Research Communications, 137, 688–694.
  • ROSELLO - CATAFAU, J., HOTTER, G., C LOSA, D., ORTIZ, M A., POU- T ORELLO, J. M., GIMENO M BIOQUE, G. and GELPI, E., 1994, Liver lipoxygenase arachidonic acid metabolites in streptozotocin- induced diabetes in rats. Prostaglandins Leukotrienes and Essential Fatty Acids, 51, 411–413.
  • ROY, S. K. and KULKARNI, A. P., 1996, Isolation and some properties of dioxygenase and co-oxidase activities of adult human liver cytosolic lipoxygenase. Journal of Biochemical Toxicology (in press).
  • ROY, S K. and K ULICARNI, A. P., 1994, Dioxygenase and co-oxidase activities of rat hepatic cytosolic lipoxygenase. Journal of Biochemical Toxicology, 9, 171–179.
  • ROY, S K., MITRA, A. K., H ILBELINK, D. R., DWORNIK, J. J. and K ULKARNI, A. P., 1993, Lipoxygenase activity in rat embryos and its potential for xenobio tic oxidation. Biology of Neonate, 63, 297–302.
  • ROY, P., S AJAN, M P. and KULKARNI, A. P., 1995, Lipoxygenase- mediated glutathione oxidation and superoxide generation. Journal of Biochemical Toxicology, 10, 111–120.
  • SHIRATORI, Y., Hi, K., T AKADA, H., KIRIYAMA, H., N AGURA, T., MATSUMOTO, K., KAMAII, K., °KANO, K. and T ANAKA, M., 1992, Mechanism of accumulation of macrophages in galactosamine-induced liver injury : effect of lipoxygenase inhibitors on chemotaxis of spleen cells. Pathobiology, 60, 316–321.
  • SIEDOW, J. N., 1991, Plant lipoxygenase: structure and function. Annual Review of Plant Physiology and Plant Molecular Biology, 42, 145–188.
  • STOHS, S. J. and Wu, L. J., 1981, Effects of prostaglandin Ei, E2, F2a and arachidonic acid on aryl hydrocarbon hydroxylase activity of intestinal and hepatic microsomes from male rats. Research Communications in Chemical Pathology and Pharmacology, 60, 1036–1043.
  • SWENSON, D. H., MILLER, E. C. and MILLER, J. A., 1974, Aflatoxin B1-2,3- oxide : evidence for its formation in rat liver in vivo and by human liver microsomes. Biochemical Biophysical Research Communications, 60, 1036–1043.
  • TlEGS, G. and WENDEL, A., 1988, Leukotriene- mediated liver injury. Biochemical Pharmacology, 37, 2569–2573.
  • UENG Y. F., S HIMADA, T., YAMAZAKI, H. and GUENGERICH, F. P., 1995, Oxidation of aflatoxin Bi by bacterial recombinant human cytochrome P450 enzymes. Chemical Research in Toxicology, 8, 218–225.
  • VAN RENSBERG, S. J., COOK - M OZAFFARI, P., VAN S CHALKWYK, D. J., VAN D ER W ATT J. J., VINCENT, T. J. and PURCHASE, I. F., 1985, Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. British Journal of Cancer, 51, 713–726.
  • YAMAMOTO, S., 1992, Mammalian lipoxygenase: molecular structure and functions. Biochimica Biophysica. Acta, 1128 117–131.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.